Heart monitor could make blood thinners safer for heart attack patients
NCT ID NCT04276155
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether an implantable heart monitor with remote follow-up can help doctors decide when to prescribe blood thinners to patients who have had a heart attack and developed new atrial fibrillation. The goal is to reduce bleeding complications compared to the standard approach of giving blood thinners based on a risk score. About 500 participants will be randomly assigned to either standard care or the implantable monitor strategy.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
implantable heart monitor with remote follow-up
What this could lead to
If successful, this could lead to a safer way to decide when to use blood thinners in heart attack patients with atrial fibrillation, reducing bleeding risks.
What could go wrong
This is a Phase 4 study, so the approach is already in use, but it may not prove safer than standard care. The implant device itself carries small risks like infection or malfunction.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION, MYOCARDIAL INFARCTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre Hospitalier d'Aix en Provence
Aix-en-Provence, France
-
Centre Hospitalier d'Annecy Genevois
Metz-Tessy, France
-
Centre Hospitalier d'Haguenau
Haguenau, France
-
Centre Hospitalier de La Rochelle
La Rochelle, France
-
Centre Hospitalier de Libournes
Libourne, France
-
Centre Hospitalier de Périgueux
Périgueux, France
-
Centre hospitalier Chartres Louis Pasteur le Coudray
Chartres, France
-
Centre hospitalier de Pau
Pau, 64046, France